RUNX1 Alterations in Pediatric Myeloid Malignancies: Divergent Germline and Somatic Trajectories
International Journal of Molecular Sciences · 26.05.2026 · 27 (11) · 4805
DOI: 10.3390/ijms27114805 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.05.2026. Verfasst von Ana Maria Bicǎ und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Medicine and Pharmacy Carol Davila, 050474 Bucharest, Romania. Hauptthemen laut MEDLINE: Core Binding Factor Alpha 2 Subunit, Germ-Line Mutation, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
RUNX1 alterations contribute to pediatric myeloid malignancies through both germline predisposition syndromes and somatic leukemogenic events, but their clinical and biological significance in children remains incompletely defined. This retrospective single-center study evaluated six pediatric patients with myelodysplastic syndromes or acute leukemias harboring RUNX1 variants, integrating clinical, cytogenetic, and targeted next-generation sequencing data, with germline status confirmed using non-hematopoietic tissues. Three patients carried germline RUNX1 variants, characterized by antecedent cytopenias, dysplastic features, and increased treatment-related toxicity, including severe infections, persistent cytopenias, and transplant-related mortality. In contrast, somatic RUNX1 alterations were associated with overt high-risk disease, frequently accompanied by complex cytogenetics or monosomy 7, and demonstrated heterogeneous outcomes ranging from sustained remission to post-transplant relapse. Mixed-phenotype acute leukemia was observed in both groups. These findings support a model of RUNX1-driven leukemogenesis, in which germline and somatic alterations represent distinct yet interconnected trajectories, while highlighting the importance of distinguishing variant origin for risk stratification, donor selection, and therapeutic decision-making in pediatric myeloid malignancies. Given the small cohort size, the findings remain descriptive and require validation in larger prospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Medicine and Pharmacy Carol Davila, 050474 Bucharest, Romania.
- Department of Pediatrics, and Bone Marrow Transplantation Unit, Fundeni Clinical Institute, 022328 Bucharest, Romania.
- Department of Hematology Laboratory, Fundeni Clinical Institute, 022328 Bucharest, Romania.
- Molecular Biology Laboratory, MedLife, 010719 Bucharest, Romania.
- Department of Hematology, Emergency University Hospital Bucharest, 050098 Bucharest, Romania.
ORCID-Profile: Andra Daniela Marcu, Cristina Georgiana Jercan, Letiția Elena Radu, Irina Avramescu, Anca Colițǎ
Zitieren
APA
Bicǎ, A. M., Marcu, A. D., Jercan, C. G., Radu, L. E., Avramescu, I., Jardan, C., Jardan, D., Cǎlugǎru, O. T., Mambet, C., & Colițǎ, A. (2026). RUNX1 Alterations in Pediatric Myeloid Malignancies: Divergent Germline and Somatic Trajectories. International Journal of Molecular Sciences, 27(11), 4805. https://doi.org/10.3390/ijms27114805
Vancouver
Bicǎ AM, Marcu AD, Jercan CG, Radu LE, Avramescu I, Jardan C, et al. RUNX1 Alterations in Pediatric Myeloid Malignancies: Divergent Germline and Somatic Trajectories. International Journal of Molecular Sciences. 2026;27(11):4805. doi:10.3390/ijms27114805
BibTeX
@article{Bic2026,
author = {Bicǎ, Ana Maria and Marcu, Andra Daniela and Jercan, Cristina Georgiana and Radu, Letiția Elena and Avramescu, Irina and Jardan, Cerasela and Jardan, Dumitru and Cǎlugǎru, Onda Tabita and Mambet, Cristina and Colițǎ, Anca},
title = {RUNX1 Alterations in Pediatric Myeloid Malignancies: Divergent Germline and Somatic Trajectories},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4805},
doi = {10.3390/ijms27114805}
}
EUVIMED